(PharmaNewsWire.Com, January 15, 2018 ) The global flow diversion aneurysm treatment market is driven by several factors that include the increase in the incidence of brain aneurysm, increase in demand for minimally invasive endovascular surgeries, and advances in technology. However, challenges such as risk of complications in cerebrovascular/neurovascular procedures, stringent regulations for the approval of devices, the high cost of flow diversion aneurysm treatment, and the increase in competition among vendors restrain the market growth.
Publisher's analysts forecast the global flow diversion aneurysm treatment market to grow at a CAGR of 14.55% during the period 2016-2020.
Covered in this report The report covers the present scenario and the growth prospects of the global flow diversion aneurysm treatment market for 2016-2020. To calculate the market size, we consider the revenue generated from the sales of flow diversion aneurysm devices to hospitals and ambulatory surgical centers (ASCs).
The market is divided into the following segments based on geography: - Americas - APAC - EMEA
Publisher's report, Global Flow Diversion Aneurysm Treatment Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
